
  
    
      
        Background_NNP
        Nociceptors_NNP are_VBP specialized_JJ primary_JJ afferent_NN neurons_NNS and_CC
        the_DT first_JJ cells_NNS in_IN the_DT series_NN of_IN neurons_NNS that_WDT lead_VBP to_TO the_DT
        sensation_NN of_IN pain_NN [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD ]_NN ._. The_DT receptors_NNS in_IN
        these_DT cells_NNS can_MD be_VB activated_VBN by_IN different_JJ noxious_JJ chemical_NN
        or_CC physical_JJ stimuli_NNS [_NN 9_CD 10_CD 11_CD ]_NN ._. The_DT essential_JJ functions_NNS
        of_IN nociceptors_NNS include_VBP the_DT transduction_NN of_IN noxious_JJ stimuli_NNS
        into_IN depolarizations_NNS that_WDT trigger_VBP action_NN potentials_NNS ,_,
        conduction_NN of_IN action_NN potentials_NNS from_IN peripheral_JJ sensory_JJ
        sites_NNS to_TO synapses_NNS in_IN the_DT central_JJ nervous_JJ system_NN ,_, and_CC
        conversion_NN of_IN action_NN potentials_NNS into_IN neurotransmitter_NN
        release_NN at_IN presynaptic_JJ terminals_NNS ,_, all_DT of_IN which_WDT depend_VBP on_IN
        ion_NN channels_NNS [_NN 6_CD 12_CD 13_CD 14_CD 15_CD 16_CD ]_NN ._. Recent_JJ expression_NN
        cloning_VBG has_VBZ led_VBN to_TO the_DT identification_NN of_IN the_DT first_JJ pain_NN
        sensory_JJ receptor_NN ._. The_DT cloned_VBN receptor_NN is_VBZ called_VBN VR_NNP 1_CD
        (_( vanilloid_NN receptor_NN subtype_NN 1_LS )_) [_NN 9_CD 10_CD ]_NN ._. The_DT nucleotide_NN
        sequence_NN of_IN VR_NNP 1_CD predicts_VBZ a_DT protein_NN of_IN 838_CD amino_JJ acids_NNS with_IN
        a_DT molecular_JJ mass_NN of_IN 95_CD kDa_NN ._. The_DT predicted_VBD topological_JJ
        organization_NN consists_VBZ of_IN six_CD transmembrane_NN domains_NNS with_IN a_DT
        hydrophobic_JJ loop_NN between_IN the_DT fifth_JJ and_CC sixth_JJ domain_NN which_WDT
        lines_NNS the_DT ion_NN conducting_VBG pore_NN [_NN 17_CD ]_NN ._. VR_NNP 1_CD has_VBZ been_VBN
        expressed_VBN heterologously_RB in_IN several_JJ cell_NN lines_NNS and_CC has_VBZ
        intrinsic_JJ sensitivity_NN to_TO thermal_JJ stimuli_NNS and_CC to_TO capsaicin_NN
        (_( a_DT pungent_JJ extract_NN of_IN the_DT 
        Capsicum_NNP pepper_NN family_NN )_) [_NN 18_CD ]_NN ._. VR_NNP 1_CD
        does_VBZ not_RB discriminate_JJ among_IN monovalent_NN cations_NNS [_NN 19_CD ]_NN ;_:
        however_RB ,_, it_PRP exhibits_VBZ a_DT notable_JJ preference_NN for_IN divalent_NN
        cations_NNS with_IN a_DT permeability_NN sequence_NN of_IN Ca_MD 2_CD +_NN >_NN Mg_NNP 2_CD +_NN >_NN
        Na_NNP +_NN ≈_NN K_NNP +_NN ≈_NN Cs_NNP +_NN [_NN 9_CD ]_NN ._. Ca_MD 2_CD +_NN is_VBZ especially_RB important_JJ to_TO VR_NNP 1_CD
        function_NN ,_, as_IN extracellular_NN Ca_MD 2_CD +_NN mediates_NNS desensitization_NN [_NN
        20_CD 21_CD ]_NN ,_, a_DT process_NN which_WDT enables_VBZ a_DT neuron_NN to_TO adapt_VB to_TO
        specific_JJ stimuli_NNS by_IN diminishing_VBG its_PRP$ overall_JJ response_NN to_TO a_DT
        particular_JJ chemical_NN or_CC physical_JJ signal_NN ._. Although_IN not_RB
        activated_VBN by_IN voltage_NN alone_RB ,_, VR_NNP 1_CD currents_NNS show_VBP outward_RB
        rectification_NN and_CC a_DT region_NN of_IN negative_JJ resistance_NN in_IN the_DT
        current-voltage_JJ relation_NN ._.
        The_DT VR_NNP 1_CD channel_NN is_VBZ a_DT member_NN of_IN the_DT superfamily_RB of_IN ion_NN
        channels_NNS with_IN six_CD membrane-spanning_JJ domains_NNS ,_, with_IN highest_JJS
        homology_NN to_TO the_DT 
        trp_NN family_NN of_IN ion_NN channels_NNS ._. For_IN those_DT
        ion_NN channels_NNS within_IN this_DT superfamily_RB for_IN which_WDT
        stoichiometry_NN has_VBZ been_VBN directly_RB examined_VBN ,_, all_DT have_VBP been_VBN
        shown_VBN to_TO be_VB composed_VBN of_IN four_CD six-transmembrane_JJ domain_NN
        subunits_NNS or_CC pseudosubunits_NNS ,_, with_IN auxiliary_JJ subunits_NNS
        sometimes_RB present_VBP as_IN well_RB [_NN 22_CD ]_NN ._. An_DT initial_JJ
        characterization_NN of_IN VR_NNP 1_CD channels_NNS expressed_VBD in_IN Cos_NNP and_CC CHO_NNP
        cells_NNS has_VBZ recently_RB revealed_VBN that_IN ,_, under_IN certain_JJ conditions_NNS ,_,
        they_PRP run_VBP as_IN multimers_NNS on_IN pseudo-native_JJ (_( PFO_NNP )_) gels_NNS ,_, with_IN
        tetramers_NNS being_VBG one_CD of_IN the_DT primary_JJ bands_NNS observed_VBD [_NN 23_CD ]_NN ._.
        Thus_RB ,_, like_IN other_JJ six_CD membrane_NN spanning_VBG domain_NN channels_NNS ,_, VR_NNP 1_CD
        almost_RB certainly_RB forms_VBZ as_IN a_DT tetramer_NN ;_: whether_IN it_PRP combines_VBZ
        with_IN homologous_RB subunits_NNS to_TO form_VB heteromeric_JJ channels_NNS
        remains_VBZ to_TO be_VB determined_VBN ._.
        In_IN this_DT study_NN we_PRP have_VBP examined_VBN the_DT electrophysiological_JJ
        and_CC biochemical_JJ properties_NNS of_IN VR_NNP 1_CD expressed_VBD in_IN 
        Xenopus_NNP oocytes_NNS ._. We_PRP found_VBD that_IN its_PRP$
        apparent_JJ affinity_NN for_IN the_DT ligand_NN capsaicin_NN is_VBZ comparable_JJ to_TO
        that_DT observed_VBN by_IN others_NNS ._. When_WRB examined_VBD for_IN size_NN on_IN
        denaturing_VBG gels_NNS ,_, we_PRP found_VBD that_IN the_DT monomer_NN appeared_VBD to_TO be_VB a_DT
        doublet_NN and_CC that_IN there_EX was_VBD a_DT band_NN that_WDT corresponded_VBD to_TO
        roughly_RB twice_RB the_DT molecular_JJ weight_NN of_IN the_DT monomer_NN bands_NNS ._.
        Through_IN site-directed_JJ mutagenesis_NNS ,_, we_PRP determined_VBD that_IN the_DT
        doublet_NN represented_VBD unglycosylated_JJ and_CC glycosylated_JJ forms_NNS
        of_IN the_DT VR_NNP 1_CD subunit_NN monomer_NN and_CC identified_VBD the_DT glycosylation_NN
        site_NN as_IN N_NNP 604_CD ._. Next_JJ ,_, using_VBG a_DT VR_NNP 1_CD subunit_NN engineered_VBN to_TO be_VB of_IN
        different_JJ size_NN ,_, we_PRP show_VBP that_IN the_DT larger_JJR band_NN on_IN the_DT gel_NN
        represented_VBD dimerized_JJ subunits_NNS ._. Several_JJ mechanisms_NNS
        underlying_VBG dimerization_NN were_VBD examined_VBN and_CC ruled_VBD out_RP ._. Since_IN
        VR_NNP 1_CD likely_JJ forms_NNS as_IN a_DT tetramer_NN ,_, the_DT strong_JJ interaction_NN we_PRP
        observed_VBD between_IN pairs_NNS of_IN subunits_NNS raises_VBZ the_DT question_NN of_IN
        whether_IN this_DT subunit_NN interaction_NN is_VBZ involved_VBN in_IN VR_NNP 1_CD
        function_NN ._.
      
      
        Results_NNS
        
          Electrophysiological_NNP and_CC biochemical_JJ properties_NNS of_IN
          VR_NNP 1_CD
          We_PRP expressed_VBD VR_NNP 1_CD channels_NNS in_IN 
          Xenopus_NNP oocytes_NNS in_IN order_NN to_TO
          characterize_VB their_PRP$ electrophysiological_JJ and_CC biochemical_JJ
          properties_NNS ._. Using_VBG outside-out_JJ patch-clamp_JJ recordings_NNS ,_, we_PRP
          studied_VBD the_DT responses_NNS of_IN the_DT channels_NNS to_TO capsaicin_NN ._.
          Figure_NN 1_CD Adepicts_NNP a_DT current_JJ family_NN obtained_VBD using_VBG a_DT
          saturating_VBG (_( 4_CD μM_NN )_) capsaicin_NN concentration_NN when_WRB the_DT
          voltage_NN was_VBD stepped_VBN from_IN a_DT holding_VBG potential_NN of_IN 0_CD mV_NN to_TO
          from_IN -_: 100_CD to_TO +_NN 100_CD mV_NN ._. A_DT current-voltage_JJ relation_NN measured_VBN
          from_IN these_DT currents_NNS (_( Figure_NN 1_CD B_NNP )_) shows_VBZ the_DT pronounced_VBN
          outward_RB rectification_NN exhibited_VBN by_IN VR_NNP 1_CD ._. This_DT
          rectification_NN has_VBZ been_VBN shown_VBN to_TO be_VB independent_JJ of_IN
          external_JJ divalent_NN cations_NNS [_NN 24_CD ]_NN ,_, and_CC is_VBZ likely_JJ due_NN to_TO a_DT
          combination_NN of_IN rectification_NN in_IN unitary_JJ conductance_NN [_NN 9_CD ]_NN
          and_CC voltage-dependent_JJ gating_VBG [_NN 24_CD ]_NN ._. Application_NNP of_IN a_DT
          lower_JJR concentration_NN of_IN capsaicin_NN (_( 0_CD ._. 5_LS μM_NN )_) activated_VBN a_DT
          smaller_JJR fraction_NN of_IN the_DT channels_NNS in_IN this_DT patch_NN ,_, giving_VBG a_DT
          smaller_JJR overall_JJ current_JJ (_( Figure_NN 1_CD C_NNP )_) ._. By_IN plotting_VBG the_DT
          normalized_JJ currents_NNS in_IN the_DT presence_NN of_IN 4_CD μM_NN and_CC 0_CD ._. 5_CD μM_NN
          capsaicin_NN on_IN the_DT same_JJ graph_NN (_( Figure_NN 1_CD D_NNP )_) ,_, we_PRP show_VBP that_IN the_DT
          voltage_NN dependence_NN remains_VBZ unaltered_JJ under_IN both_DT
          experimental_JJ conditions_NNS ._. Figure_NN 1_CD Eshows_NNP a_DT dose-response_JJ
          relation_NN for_IN activation_NN of_IN VR_NNP 1_CD channels_NNS by_IN capsaicin_NN for_IN
          the_DT same_JJ patch_NN ._. Fits_NNP of_IN dose-response_JJ relations_NNS with_IN the_DT
          Hill_NNP equation_NN (_( see_VB Experimental_NNP Procedures_NNP )_) yielded_VBD
          values_NNS of_IN n_NN =_SYM 1_CD ._. 8_CD ±_NN 0_CD ._. 06_CD and_CC a_DT K_NNP 
          ½ =_SYM 614_CD ±_NN 110_CD nM_NN (_( mean_NN of_IN 5_CD patches_NNS )_) ._.
          These_DT values_NNS are_VBP similar_JJ to_TO those_DT previously_RB reported_VBN [_NN
          20_CD 24_CD ]_NN ._. These_DT data_NNS indicate_VBP that_IN in_IN our_PRP$ system_NN VR_NNP 1_CD RNA_NNP
          is_VBZ expressed_VBN as_IN a_DT functional_JJ protein_NN with_IN characteristics_NNS
          similar_JJ to_TO those_DT reported_VBN by_IN other_JJ groups_NNS ._.
          To_TO examine_VB the_DT size_NN of_IN VR_NNP 1_CD with_IN SDS_NNP /_NN PAGE_NNP ,_, we_PRP
          constructed_VBN a_DT VR_NNP 1_CD subunit_NN with_IN a_DT FLAG_NNP epitope_NN tag_NN on_IN its_PRP$
          extreme_JJ C-_NNP terminal_NN end_NN (_( Figure_NN 2_CD A_DT )_) ._. By_IN using_VBG both_PDT this_DT
          C-_NNP terminal_NN FLAG_NNP epitope_NN and_CC an_DT N-_NNP terminal_NN epitope_NN for_IN
          which_WDT a_DT commercial_JJ antibody_NN is_VBZ available_JJ ,_, we_PRP could_MD
          determine_VB whether_IN the_DT band_NN (_( s_VBZ )_) we_PRP observed_VBD corresponded_VBD to_TO
          full-length_JJ VR_NNP 1_CD subunits_NNS ._. When_WRB oocytes_NNS injected_VBN with_IN VR_NNP 1_CD
          RNA_NNP were_VBD examined_VBN with_IN SDS_NNP /_NN PAGE_NNP and_CC Western_JJ blot_NN ,_, three_CD
          bands_NNS were_VBD apparent_JJ (_( Figures_NNS 2_CD B_NNP ,_, 2_CD C_NNP ,_, 2_CD D_NNP )_) ._. Two_CD of_IN these_DT
          bands_NNS were_VBD seen_VBN as_IN a_DT doublet_NN at_IN about_IN 80_CD kDa_NN and_CC 84_CD kDa_NN
          (_( best_RBS seen_VBN in_IN Figure_NN 2_CD D_NNP )_) ._. A_DT third_JJ band_NN of_IN about_IN 200_CD kDa_NN
          was_VBD also_RB observed_VBN ._. The_DT size_NN of_IN these_DT bands_NNS was_VBD the_DT same_JJ
          for_IN blots_NNS probed_JJ with_IN the_DT N-_NNP terminal_NN antibody_NN (_( Figure_NN 2_CD B_NNP )_)
          or_CC the_DT FLAG_NNP antibody_NN (_( Figure_NN 2_CD C_NNP )_) ,_, indicating_VBG that_IN they_PRP
          represent_VBP full-length_JJ VR_NNP 1_CD subunits_NNS ._. For_IN the_DT remainder_NN of_IN
          this_DT study_NN we_PRP used_VBD the_DT FLAG_NNP antibody_NN due_JJ to_TO the_DT lower_JJR
          background_NN it_PRP produced_VBD ._.
        
        
          Identification_NNP of_IN the_DT glycosylation_NN site_NN in_IN
          VR_NNP 1_CD
          A_DT doublet_NN of_IN monomers_NNS has_VBZ been_VBN previously_RB observed_VBN for_IN
          VR_NNP 1_CD expressed_VBD in_IN CHO_NNP cells_NNS [_NN 23_CD ]_NN ._. In_IN that_DT case_NN ,_,
          treatment_NN of_IN cells_NNS with_IN peptide-_NN 
          N_NNP -_: glycosidase_NN F_NN eliminated_VBD the_DT
          larger_JJR monomer_NN band_NN ,_, suggesting_VBG that_IN it_PRP represented_VBD a_DT
          glycosylated_JJ form_NN of_IN VR_NNP 1_CD ._. Although_IN the_DT difference_NN in_IN
          apparent_JJ size_NN in_IN that_DT study_NN was_VBD 19_CD kDa_NN and_CC we_PRP see_VBP a_DT
          difference_NN of_IN only_RB 4_CD kDa_NN (_( Figure_NN 2_CD C_NNP )_) ,_, we_PRP wondered_VBD whether_IN
          glycosylation_NN might_MD explain_VB our_PRP$ doublet_NN as_RB well_RB ._. We_PRP
          therefore_RB examined_VBD the_DT predicted_VBD amino_JJ acid_NN sequence_NN of_IN
          VR_NNP 1_CD in_IN order_NN to_TO identify_VB potential_JJ glycosylation_NN sites_NNS
          (_( see_VB Experimental_NNP Procedures_NNP )_) ._. Figure_NN 2_CD Adepicts_NNP the_DT
          proposed_VBN topology_NN of_IN the_DT six_CD transmembrane_NN domains_NNS of_IN
          VR_NNP 1_CD ._. A_DT consensus_NN sequence_NN for_IN N-_NNP linked_VBD glycosylation_NN is_VBZ
          located_VBN just_RB distal_NN to_TO the_DT fifth_JJ transmembrane_NN domain_NN at_IN
          position_NN 604_CD ._. We_PRP introduced_VBD a_DT point_NN mutation_NN to_TO change_VB
          the_DT asparagine_NN at_IN position_NN 604_CD into_IN a_DT serine_NN (_( N_NNP 604_CD S_NNP )_) ._. If_IN
          indeed_RB N_NNP 604_CD is_VBZ a_DT glycosylation_NN site_NN ,_, channels_NNS expressed_VBD
          from_IN this_DT N_NNP 604_CD S_NNP construct_VB would_MD be_VB expected_VBN to_TO lack_NN
          glycosylation_NN ._. Figure_NN 2_CD Dshows_NNP that_IN in_IN N_NNP 604_CD S_NNP channels_NNS the_DT
          upper_JJ band_NN of_IN the_DT doublet_NN has_VBZ been_VBN eliminated_VBN ._. These_DT data_NNS
          indicate_VBP that_IN wild-type_JJ VR_NNP 1_CD channels_NNS expressed_VBD in_IN 
          Xenopus_NNP oocytes_NNS are_VBP present_JJ in_IN both_DT
          unglycosylated_JJ and_CC glycosylated_JJ forms_NNS and_CC that_IN the_DT
          N-_NNP linked_VBD glycosylation_NN occurs_VBZ at_IN position_NN 604_CD ._.
          Once_RB we_PRP determined_VBD that_IN the_DT N_NNP 604_CD S_NNP mutation_NN efficiently_RB
          removed_VBD the_DT glycosylated_JJ form_NN of_IN the_DT monomer_NN ,_, we_PRP tested_VBD
          to_TO be_VB certain_JJ that_IN N_NNP 604_CD S_NNP channels_NNS were_VBD present_JJ in_IN the_DT
          plasma_NN membrane_NN and_CC had_VBD electrophysiological_JJ
          characteristics_NNS similar_JJ to_TO those_DT observed_VBD in_IN wild-type_JJ
          channels_NNS ._. We_PRP performed_VBD patch-clamp_JJ recordings_NNS on_IN oocytes_NNS
          injected_VBN with_IN N_NNP 604_CD S_NNP RNA_NNP ._. The_DT results_NNS of_IN these_DT experiments_NNS
          are_VBP shown_VBN in_IN Figure_NN 3_CD ._. Like_IN for_IN wild-type_JJ VR_NNP 1_CD channels_NNS ,_,
          capsaicin_NN activated_VBN N_NNP 604_CD S_NNP channels_NNS in_IN a_DT
          concentration-dependent_JJ manner_NN (_( Figures_NNS 3_CD A_DT ,_, 3_CD C_NNP ,_, and_CC 3_CD E_NNP )_) ._.
          Current_JJ voltage_NN relations_NNS at_IN both_DT a_DT saturating_VBG (_( Figure_NN
          3_CD B_NNP )_) and_CC a_DT subsaturating_VBG (_( Figure_NN 3_CD D_NNP )_) concentration_NN of_IN
          capsaicin_NN show_NN that_IN the_DT voltage_NN dependence_NN of_IN N_NNP 604_CD S_NNP
          channels_NNS is_VBZ similar_JJ to_TO that_DT of_IN wild-type_JJ VR_NNP 1_CD channels_NNS (_( in_IN
          Figure_NN 3_CD compare_VB data_NNS from_IN N_NNP 604_CD S_NNP channels_NNS [_NN blue_JJ and_CC red_JJ ]_NN
          to_TO data_NNS from_IN wild-type_JJ VR_NNP 1_CD channels_NNS [_NN green_JJ ]_NN )_) :_: the_DT ratio_NN
          of_IN the_DT current_NN at_IN +_NN 100_CD mV_NN to_TO that_DT at_IN -_: 100_CD mV_NN is_VBZ not_RB
          statistically_RB different_JJ from_IN wild-type_JJ VR_NNP 1_CD ._. Furthermore_RB ,_,
          the_DT dose-response_JJ relation_NN in_IN Figure_NN 3_CD Eshows_NNP that_IN the_DT
          apparent_JJ affinity_NN of_IN N_NNP 604_CD S_NNP channels_NNS for_IN capsaicin_NN is_VBZ not_RB
          significantly_RB different_JJ from_IN wild-type_JJ channels_NNS (_( t-test_JJ ,_,
          p_NN >_NN 0_CD ._. 05_CD )_) ,_, with_IN n_NN =_SYM 2_CD ._. 3_CD ±_NN 0_CD ._. 3_CD and_CC K_NNP 
          ½ =_SYM 780_CD ±_NN 71_CD nM_NN (_( mean_NN of_IN 5_CD patches_NNS )_) ._.
          These_DT data_NNS indicate_VBP that_IN eliminating_VBG the_DT N-_NNP glycosylation_NN
          site_NN of_IN the_DT VR_NNP 1_CD channel_NN gives_VBZ rise_NN to_TO a_DT functional_JJ
          protein_NN electrophysiologically_RB similar_JJ to_TO wild-type_JJ
          VR_NNP 1_CD ._.
        
        
          Identification_NNP of_IN the_DT nature_NN of_IN the_DT VR_NNP 1_CD high_JJ
          molecular_JJ size_NN band_NN
          At_IN 200_CD kDa_NN ,_, the_DT third_JJ band_NN observed_VBD in_IN Figure_NN 2_CD was_VBD
          approximately_RB twice_RB the_DT molecular_JJ weight_NN of_IN the_DT monomer_NN ._.
          We_PRP therefore_RB suspected_VBD that_IN it_PRP might_MD represent_VB a_DT dimer_NN of_IN
          VR_NNP 1_CD subunits_NNS ._. However_RB ,_, it_PRP could_MD also_RB arise_VB from_IN a_DT monomer_NN
          in_IN combination_NN with_IN another_DT cellular_JJ factor_NN ._. To_TO
          distinguish_VB between_IN these_DT possibilities_NNS ,_, we_PRP engineered_VBN a_DT
          VR_NNP 1_CD mutant_JJ in_IN which_WDT amino_JJ acids_NNS 2_CD -_: 52_CD in_IN the_DT N-_NNP terminal_NN
          were_VBD deleted_VBN (_( termed_VBD Δ_NN 2_CD -_: 52_CD )_) ._. This_DT construct_VB gave_VBD rise_NN to_TO
          a_DT high_JJ molecular_JJ weight_NN band_NN of_IN 180_CD kDa_NN ,_, 20_CD kDa_NN smaller_JJR
          than_IN that_DT observed_VBD for_IN wild-type_JJ VR_NNP 1_CD (_( Figure_NN 4_LS )_) ._. When_WRB
          coexpressed_JJ with_IN VR_NNP 1_CD ,_, heteromeric_JJ channels_NNS composed_VBN of_IN
          both_DT types_NNS of_IN subunits_NNS are_VBP expected_VBN to_TO form_VB ._. If_IN the_DT
          higher_JJR molecular_JJ weight_NN band_NN does_VBZ represent_VB a_DT dimer_NN of_IN
          subunits_NNS ,_, the_DT heteromeric_JJ VR_NNP 1_CD /_NN Δ_NN 2_CD -_: 52_CD ought_MD to_TO be_VB
          intermediate_JJ in_IN size_NN between_IN the_DT homomeric_JJ dimers_NNS ._. When_WRB
          equal_JJ amounts_NNS of_IN VR_NNP 1_CD and_CC Δ_NN 2_CD -_: 52_CD RNA_NNP 's_POS were_VBD coinjected_JJ into_IN
          oocytes_NNS ,_, three_CD bands_NNS were_VBD observed_VBN :_: 200_CD ,_, 190_CD and_CC 180_CD kDa_NN
          (_( Figure_NN 4_LS )_) ._. The_DT 200_CD kDa_NN band_NN represents_VBZ the_DT homomeric_JJ VR_NNP 1_CD
          dimer_NN whereas_IN the_DT 180_CD kDa_NN band_NN represent_VBP the_DT homomeric_JJ
          Δ_NN 2_CD -_: 52_CD dimer_NN ._. The_DT middle_JJ band_NN ,_, at_IN 190_CD kDa_NN ,_, is_VBZ indeed_RB
          intermediate_JJ in_IN size_NN ._. Our_PRP$ interpretation_NN is_VBZ that_IN this_DT 190_CD
          kDa_NN band_NN is_VBZ composed_VBN of_IN one_CD wild-type_JJ VR_NNP 1_CD subunit_NN and_CC one_CD
          Δ_NN 2_CD -_: 52_CD subunit_NN ,_, indicating_VBG that_IN the_DT high_JJ molecular_JJ weight_NN
          band_NN represents_VBZ subunit_NN dimers_NNS ._. Furthermore_RB ,_,
          quantification_NN of_IN the_DT intensity_NN of_IN the_DT bands_NNS on_IN the_DT gel_NN
          revealed_VBD a_DT 1_CD :_: 2_CD :_: 1_CD ratio_NN of_IN the_DT three_CD bands_NNS ._. This_DT ratio_NN of_IN
          the_DT three_CD ways_NNS in_IN which_WDT the_DT two_CD types_NNS of_IN subunit_NN can_MD
          assemble_VB is_VBZ what_WP would_MD be_VB expected_VBN if_IN assembly_NN between_IN
          the_DT different_JJ types_NNS of_IN subunits_NNS were_VBD random_JJ ._.
          Next_JJ ,_, as_IN with_IN N_NNP 604_CD S_NNP ,_, we_PRP wanted_VBD to_TO be_VB certain_JJ that_DT
          Δ_NN 2_CD -_: 52_CD expressed_VBD as_IN a_DT functional_JJ channel_NN in_IN 
          Xenopus_NNP oocytes_NNS ._. The_DT results_NNS of_IN
          electrophysiological_JJ experiments_NNS are_VBP shown_VBN in_IN Figure_NN 5_CD ._.
          We_PRP found_VBD Δ_NN 2_CD -_: 52_CD to_TO form_VB functional_JJ ,_, capsaicin-activated_JJ
          channels_NNS in_IN 
          Xenopus_NNP oocytes_NNS ._. Although_IN an_DT
          increase_NN in_IN rectification_NN was_VBD consistently_RB observed_VBN with_IN
          these_DT channels_NNS ,_, compared_VBN to_TO wild-type_JJ VR_NNP 1_CD (_( Figure_NN 5_CD B_NNP )_) ,_,
          the_DT ratio_NN of_IN the_DT current_NN at_IN +_NN 100_CD mV_NN to_TO that_DT at_IN -_: 100_CD mV_NN is_VBZ
          not_RB statistically_RB different_JJ from_IN wild-type_JJ VR_NNP 1_CD ._. Fits_NNP of_IN
          dose-response_JJ relations_NNS (_( Figure_NN 5_CD E_NNP )_) with_IN the_DT Hill_NNP
          equation_NN yielded_VBD a_DT mean_JJ n_NN value_NN of_IN 2_CD ._. 1_CD ±_NN 0_CD ._. 26_CD ,_, and_CC a_DT mean_NN
          K_NNP 
          ½ value_NN of_IN 1_CD ._. 98_CD ±_NN 0_CD ._. 8_CD μM_NN ;_: neither_DT n_NN
          nor_CC K_NNP 
          ½ were_VBD significantly_RB different_JJ from_IN
          VR_NNP 1_CD (_( t-test_JJ ,_, p_NN >_NN 0_CD ._. 05_CD ,_, for_IN 5_CD patches_NNS )_) ._.
        
        
          Examination_NNP of_IN putative_JJ cross-linking_JJ
          factors_NNS
          A_DT previous_JJ study_NN has_VBZ reported_VBN that_IN the_DT presence_NN of_IN
          capsaicin_NN and_CC chemical_NN cross-linkers_JJ influence_NN the_DT
          formation_NN of_IN multimers_NNS in_IN VR_NNP 1_CD [_NN 23_CD ]_NN ._. Moreover_RB ,_, this_DT
          study_NN reported_VBD that_IN cross-linking_JJ could_MD be_VB a_DT Ca_MD
          2_CD +_NN mediated_JJ process_NN ,_, through_IN the_DT activation_NN of_IN endogenous_JJ
          transglutaminases_NNS ._. In_IN our_PRP$ expression_NN system_NN ,_, the_DT presence_NN
          of_IN a_DT dimer_NN was_VBD seen_VBN even_RB in_IN the_DT absence_NN of_IN capsaicin_NN ._.
          Thus_RB ,_, we_PRP set_VBD out_IN to_TO study_VB the_DT factors_NNS that_WDT could_MD be_VB
          involved_VBN in_IN the_DT formation_NN of_IN this_DT complex_NN ._. Our_PRP$ first_JJ
          approach_NN was_VBD to_TO determine_VB whether_IN this_DT dimer_NN could_MD be_VB due_JJ
          to_TO the_DT presence_NN of_IN a_DT disulfide_NN bond_NN between_IN subunits_NNS ._.
          Although_IN we_PRP have_VBP β-mercaptoethanol_JJ in_IN the_DT sample_NN buffer_NN
          for_IN all_DT experiments_NNS ,_, it_PRP is_VBZ possible_JJ that_IN a_DT disulfide_NN bond_NN
          refractory_JJ to_TO reduction_NN by_IN this_DT reagent_NN was_VBD present_JJ ._. We_PRP
          therefore_RB used_VBD the_DT stronger_JJR reducing_VBG agents_NNS DTT_NNP and_CC TCEP_NNP
          in_IN the_DT biochemical_JJ assays_NNS ,_, and_CC used_VBD them_PRP in_IN various_JJ steps_NNS
          of_IN the_DT purification_NN (_( see_VB Materials_NNPS and_CC methods_NNS )_) ._. Figure_NN
          6_CD Ashows_NNP the_DT results_NNS for_IN this_DT experiment_NN ._. The_DT control_NN lane_NN
          represents_VBZ the_DT results_NNS obtained_VBN from_IN oocytes_NNS processed_VBN
          under_IN control_NN conditions_NNS (_( with_IN β-mercaptoethanol_JJ as_IN the_DT
          only_RB reducing_VBG agent_NN )_) ._. The_DT next_JJ two_CD lanes_NNS shown_VBN are_VBP those_DT
          of_IN oocytes_NNS exposed_VBN to_TO the_DT reducing_VBG agents_NNS DTT_NNP (_( 100_CD mM_NN )_)
          and_CC TCEP_NNP (_( 20_CD mM_NN )_) both_DT during_IN processing_NN and_CC in_IN the_DT sample_NN
          buffer_NN ._. We_PRP quantified_VBN the_DT ratio_NN of_IN intensity_NN of_IN the_DT
          monomer_NN band_NN to_TO the_DT dimer_NN band_NN ._. Neither_DT DTT_NNP nor_CC TCEP_NNP
          treatment_NN produced_VBD a_DT difference_NN in_IN this_DT ratio_NN compared_VBN to_TO
          the_DT control_NN condition_NN (_( t-test_JJ ,_, p_NN >_NN 0_CD ._. 05_CD for_IN 3_CD
          independent_JJ experiments_NNS )_) ._. These_DT data_NNS indicate_VBP that_IN the_DT
          presence_NN of_IN the_DT VR_NNP 1_CD dimer_NN is_VBZ likely_JJ not_RB due_JJ to_TO an_DT
          intersubunit_NN disulfide_NN bond_NN ._.
          We_PRP next_RB addressed_VBN whether_IN Ca_MD 2_CD +_NN could_MD affect_VB the_DT
          monomer_NN :_: dimer_NN ratio_NN in_IN our_PRP$ expression_NN system_NN ._. Oocytes_NNP
          were_VBD processed_VBN for_IN biochemical_JJ assays_NNS under_IN the_DT various_JJ
          experimental_JJ conditions_NNS depicted_VBN in_IN Figure_NN 6_CD B_NNP ._. In_IN the_DT
          first_JJ lane_NN we_PRP show_VBP protein_NN obtained_VBN from_IN oocytes_NNS exposed_VBN
          to_TO Ca_MD 2_CD +_NN (_( 1_CD ._. 8_CD mM_NN in_IN frog_NN Ringer_NNP 's_POS solution_NN )_) but_CC not_RB to_TO
          capsaicin_NN ;_: both_DT monomer_NN and_CC dimer_NN bands_NNS can_MD be_VB observed_VBN ._.
          When_WRB capsaicin_NN and_CC Ca_MD 2_CD +_NN were_VBD added_VBN together_RB ,_, the_DT ratio_NN of_IN
          monomer_NN :_: dimer_NN remained_VBD unchanged_JJ in_IN comparison_NN to_TO the_DT
          previous_JJ experiment_NN (_( p_NN >_NN 0_CD ._. 05_CD ,_, for_IN 3_CD independent_JJ
          experiments_NNS )_) ._. We_PRP then_RB tested_VBD whether_IN eliminating_VBG Ca_MD
          2_CD +_NN from_IN the_DT oocyte_NN media_NNS would_MD affect_VB this_DT ratio_NN ._. As_IN seen_VBN
          in_IN the_DT last_JJ two_CD lanes_NNS of_IN this_DT gel_NN ,_, the_DT presence_NN of_IN EGTA_NNP
          (_( 2_CD mM_NN )_) did_VBD not_RB alter_VB the_DT formation_NN of_IN the_DT VR_NNP 1_CD dimer_NN ,_,
          whether_IN capsaicin_NN was_VBD or_CC was_VBD not_RB present_JJ in_IN the_DT assay_NN -_:
          the_DT monomer_NN :_: dimer_NN ratio_NN did_VBD not_RB differ_VB from_IN control_NN
          conditions_NNS (_( p_NN >_NN 0_CD ._. 05_CD ,_, for_IN 3_CD independent_JJ experiments_NNS
          under_IN the_DT same_JJ conditions_NNS )_) ._. Our_PRP$ data_NNS indicate_VBP that_IN under_IN
          our_PRP$ experimental_JJ conditions_NNS Ca_MD 2_CD +_NN does_VBZ not_RB play_VB a_DT pivotal_JJ
          role_NN in_IN VR_NNP 1_CD dimerization_NN ._.
          Finally_RB ,_, we_PRP tested_VBD whether_IN the_DT transglutaminase_NN
          inhibitors_NNS cysteamine_NN and_CC monodansylcadaverine_NN (_( MDC_NNP )_)
          could_MD affect_VB this_DT process_NN ._. As_IN shown_VBN in_IN Figure_NN 6_CD C_NNP (_( second_JJ
          and_CC third_JJ lanes_NNS )_) ,_, the_DT addition_NN of_IN these_DT compounds_NNS for_IN 1_CD
          hr_NN to_TO the_DT solution_NN bathing_NN the_DT oocytes_NNS and_CC to_TO the_DT
          homogenization_NN solution_NN did_VBD not_RB modify_VB the_DT monomer_NN :_: dimer_NN
          ratio_NN when_WRB compared_VBN to_TO the_DT control_NN lane_NN (_( p_NN >_NN 0_CD ._. 05_CD ,_, for_IN
          3_CD independent_JJ experiments_NNS )_) ._. The_DT concentrations_NNS of_IN
          cysteamine_NN and_CC MDC_NNP used_VBD here_RB are_VBP identical_JJ to_TO those_DT
          previously_RB shown_VBN to_TO disrupt_VB transglutaminase-induced_JJ
          cross-linking_JJ of_IN VR_NNP 1_CD channels_NNS in_IN other_JJ cell_NN types_NNS (_( Kedei_NNP 
          et_CC al_NN ._. ,_, 2001_CD )_) ._. This_DT result_NN comes_VBZ
          as_IN no_DT surprise_NN since_IN transglutaminases_NNS are_VBP known_VBN to_TO be_VB Ca_MD
          2_CD +_NN dependent_JJ [_NN 25_CD ]_NN ,_, and_CC our_PRP$ previous_JJ experiment_NN
          demonstrates_VBZ that_WDT Ca_MD 2_CD +_NN has_VBZ no_DT effect_NN on_IN the_DT dimerization_NN
          we_PRP observed_VBD ._.
        
      
      
        Discussion_NNP
        
          Unglycosylated_NNP and_CC glycosylated_JJ forms_NNS of_IN the_DT VR_NNP 1_CD
          monomer_NN
          We_PRP show_VBP that_IN ,_, in_IN 
          Xenopus_NNP oocytes_NNS ,_, VR_NNP 1_CD is_VBZ expressed_VBN
          in_IN both_DT glycosylated_JJ and_CC unglycosylated_JJ forms_NNS ,_, with_IN ~_NN 4_CD
          kDa_NN difference_NN in_IN their_PRP$ apparent_JJ molecular_JJ weights_NNS ._. The_DT
          complete_JJ disappearance_NN of_IN the_DT upper_JJ band_NN of_IN the_DT monomer_NN
          doublet_NN for_IN the_DT N_NNP 604_CD S_NNP mutation_NN strongly_RB suggests_VBZ that_IN the_DT
          extracellular_NN linker_NN between_IN the_DT fifth_JJ transmembrane_NN
          domain_NN and_CC the_DT P-_NNP loop_NN of_IN VR_NNP 1_CD is_VBZ subject_JJ to_TO N-_NNP linked_VBD
          glycosylation_NN ._. Moreover_RB ,_, since_IN channel_NN function_NN did_VBD not_RB
          appear_VB to_TO be_VB affected_VBN by_IN the_DT absence_NN of_IN glycosylation_NN
          (_( Figure_NN 3_LS )_) ,_, it_PRP appears_VBZ that_DT glycosylation_NN at_IN this_DT site_NN is_VBZ
          not_RB essential_JJ for_IN correct_JJ folding_NN and_CC targeting_VBG of_IN the_DT
          protein_NN to_TO the_DT plasma_NN membrane_NN ._.
          The_DT position_NN of_IN the_DT glycosylation_NN site_NN in_IN the_DT
          structure_NN of_IN the_DT channels_NNS is_VBZ in_IN a_DT region_NN of_IN known_VBN
          importance_NN in_IN channel_NN function_NN ._. Lying_NNP between_IN the_DT fifth_JJ
          transmembrane_NN domain_NN and_CC the_DT P-_NNP loop_NN ,_, this_DT region_NN
          contributes_VBZ to_TO the_DT extracellular_NN vestibule_NN of_IN the_DT
          ion-conducting_JJ pore_NN [_NN 26_CD ]_NN ._. The_DT vestibules_NNS of_IN ion_NN
          channels_NNS are_VBP thought_VBN to_TO influence_VB the_DT permeation_NN of_IN ions_NNS
          [_NN 27_CD 28_CD ]_NN and_CC in_IN CNG_NNP channels_NNS it_PRP has_VBZ been_VBN reported_VBN that_DT
          elimination_NN of_IN the_DT N-_NNP glycosylation_NN site_NN (_( which_WDT is_VBZ in_IN an_DT
          analogous_JJ position_NN between_IN S_NNP 5_CD and_CC the_DT P-_NNP loop_NN )_) can_MD induce_VB
          changes_NNS in_IN the_DT apparent_JJ half-blocking_JJ constants_NNS for_IN
          extracellular_NN and_CC intracellular_NN Mg_NNP 2_CD +_NN [_NN 29_CD ]_NN ._.
          Whereas_IN two_CD monomer_NN bands_NNS had_VBD been_VBN previously_RB observed_VBN
          for_IN VR_NNP 1_CD expressed_VBD in_IN CHO_NNP cells_NNS [_NN 23_CD ]_NN ,_, a_DT major_JJ
          difference_NN between_IN this_DT study_NN and_CC ours_PRP is_VBZ the_DT difference_NN
          in_IN size_NN between_IN the_DT two_CD monomer_NN bands_NNS (_( 19_CD kDa_NN -_: about_IN
          five_CD times_NNS larger_JJR than_IN we_PRP observe_VBP )_) ._. On_IN the_DT other_JJ hand_NN ,_,
          Kedei_NNP 
          et_CC al_NN ._. [_NN 23_CD ]_NN show_NN a_DT doublet_NN in_IN
          channels_NNS purified_JJ from_IN DRG_NNP cells_NNS ,_, which_WDT express_VBP VR_NNP 1_CD
          endogenously_RB ,_, that_WDT is_VBZ similar_JJ to_TO the_DT one_CD we_PRP observe_VBP ._.
          Further_RB ,_, unlike_IN in_IN CHO_NNP cells_NNS ,_, no_DT additional_JJ high_JJ
          molecular_JJ weight_NN glycosylated_JJ bands_NNS were_VBD observed_VBN ._.
        
        
          Dimerization_NNP of_IN VR_NNP 1_CD
          As_IN a_DT member_NN of_IN the_DT six-transmembrane_JJ domain_NN
          superfamily_RB of_IN ion_NN channels_NNS ,_, VR_NNP 1_CD most_RBS likely_JJ assembles_NNS
          into_IN tetrameric_JJ complexes_NNS ._. Evidence_NN that_IN VR_NNP 1_CD is_VBZ capable_JJ
          of_IN forming_VBG multimers_NNS has_VBZ been_VBN previously_RB reported_VBN when_WRB
          studied_VBN under_IN pseudo-native_JJ conditions_NNS [_NN 23_CD ]_NN ._. In_IN this_DT
          previous_JJ study_NN ,_, tetramers_NNS were_VBD the_DT major_JJ band_NN observed_VBD ,_,
          although_IN larger_JJR and_CC smaller_JJR bands_NNS were_VBD also_RB seen_VBN ._.
          Interestingly_RB ,_, there_EX is_VBZ precedent_NN for_IN an_DT ion_NN channel_NN to_TO
          retain_VB some_DT intersubunit_NN interactions_NNS even_RB on_IN denaturing_VBG
          gels_NNS like_IN those_DT used_VBN here_RB ._. The_DT bacterial_JJ K_NNP +_NN channel_NN KcsA_NNP ,_,
          whose_WP$ X-_NNP ray_NN crystal_NN structure_NN has_VBZ been_VBN solved_VBN and_CC is_VBZ
          definitively_RB a_DT tetramer_NN [_NN 30_CD ]_NN ,_, runs_VBZ as_IN a_DT tetramer_NN on_IN
          SDS_NNP gels_NNS [_NN 31_CD ]_NN ._. Furthermore_RB ,_, mutations_NNS that_WDT disrupt_VB a_DT
          known_VBN intersubunit_NN interface_NN at_IN the_DT level_NN of_IN the_DT pore_NN
          disrupt_VB this_DT biochemical_JJ tetramerization_NN ._. The_DT structural_JJ
          interactions_NNS that_WDT underlie_VB tetramerization_NN of_IN KcsA_NNP on_IN
          gels_NNS are_VBP disrupted_VBN only_RB by_IN heating_VBG the_DT sample_NN and_CC by_IN pH_NN
          12_CD [_NN 31_CD ]_NN ,_, treatments_NNS that_WDT had_VBD no_DT effect_NN on_IN the_DT
          dimerization_NN of_IN VR_NNP 1_CD we_PRP observed_VBD (_( data_NNS not_RB shown_VBN )_) ._.
          Although_IN it_PRP is_VBZ tempting_JJ to_TO conclude_VB that_IN the_DT pH-_NN and_CC
          heat-resistent_JJ dimerization_NN we_PRP observe_VBP with_IN VR_NNP 1_CD results_NNS
          from_IN a_DT covalent_NN interaction_NN ,_, we_PRP cannot_NN rule_NN out_IN other_JJ
          explanations_NNS such_JJ as_IN strong_JJ hydrophobic_JJ interactions_NNS ._.
          What_WP does_VBZ a_DT dimer_NN observed_VBD on_IN a_DT gel_NN mean_NN given_VBN that_IN
          the_DT channels_NNS are_VBP almost_RB certainly_RB tetramers_NNS ?_. Precedent_NNP
          for_IN dimerization_NN of_IN limited_JJ domains_NNS of_IN ion_NN channels_NNS
          abounds_VBZ ._. Cyclic_NNP nucleotide-gated_JJ channels_NNS ,_, for_IN example_NN ,_,
          appear_VB to_TO exhibit_VB functional_JJ dimerization_NN of_IN their_PRP$ cyclic_JJ
          nucleotide-binding_JJ domains_NNS [_NN 32_CD ]_NN ._. The_DT "_'' RCK_NNP "_'' domain_NN of_IN
          BK_NNP channels_NNS has_VBZ a_DT dimerization_NN domain_NN even_RB though_IN BK_NNP
          channels_NNS ,_, too_RB ,_, are_VBP tetrameric_JJ at_IN the_DT level_NN of_IN the_DT pore_NN [_NN
          33_CD ]_NN ._. Finally_RB ,_, the_DT GluR_NNP 2_CD ligand-binding_JJ core_NN has_VBZ a_DT
          dimerization_NN interface_NN in_IN the_DT crystal_NN structure_NN [_NN 34_CD ]_NN ._.
          Evidence_NN ,_, including_VBG the_DT clustering_VBG of_IN residues_NNS involved_VBN
          in_IN receptor_NN desensitization_NN at_IN this_DT interface_NN ,_, suggests_VBZ
          that_IN the_DT dimerization_NN is_VBZ not_RB just_RB crystallographic_JJ but_CC
          functional_JJ ._. The_DT dimerization_NN observed_VBD in_IN the_DT above_JJ
          examples_NNS all_DT involve_VBP ligand-binding_JJ sites_NNS ._. Given_VBN that_IN VR_NNP 1_CD
          is_VBZ also_RB a_DT ligand-activated_JJ ion_NN channel_NN it_PRP is_VBZ tempting_JJ to_TO
          speculate_VB that_IN it_PRP may_MD too_RB contain_VB such_PDT a_DT dimer_NN interface_NN ._.
          Recent_JJ work_NN identifying_VBG amino_JJ acid_NN residues_NNS that_IN likely_JJ
          comprise_VBP part_NN of_IN the_DT capsaicin-binding_JJ site_NN [_NN 35_CD ]_NN
          suggest_VBP that_IN capsaicin_NN binds_NNS at_IN the_DT interface_NN between_IN
          transmembrane_NN segment_NN 3_CD and_CC the_DT cytoplasm_NN ._. Could_MD this_DT be_VB
          a_DT point_NN of_IN intersubunit_NN contact_NN ?_. Although_IN the_DT
          dimerization_NN we_PRP observe_VBP may_MD represent_VB a_DT native_JJ
          intersubunit_NN interaction_NN ,_, other_JJ possibilities_NNS must_MD be_VB
          considered_VBN ._. For_IN example_NN ,_, hydrophobic_JJ interactions_NNS can_MD
          cause_VB membrane_NN proteins_NNS to_TO aggregate_JJ during_IN purification_NN ._.
          Alternatively_RB ,_, a_DT covalent_NN interaction_NN may_MD link_VB pairs_NNS of_IN
          subunits_NNS ._. This_DT possibility_NN will_MD be_VB investigated_VBN in_IN the_DT
          future_NN ._.
        
      
      
        Materials_NNS and_CC methods_NNS
        
          Heterologous_NNP expression_NN of_IN channels_NNS in_IN Xenopus_NNP
          oocytes_NNS
          Segments_NNP of_IN ovary_JJ were_VBD removed_VBN from_IN anesthetized_JJ 
          Xenopus_NNP laevis_NNS ._. After_IN gross_JJ
          mechanical_JJ isolation_NN ,_, individual_JJ oocytes_NNS were_VBD
          defolliculated_JJ by_IN incubation_NN with_IN collagenase_NN 1_CD A_DT (_( 1_CD
          mg_NN /_NN mL_NN )_) in_IN Ca_MD 2_CD +_NN -_: free_JJ OR_NNP 2_CD medium_NN (_( 82_CD ._. 5_LS mM_NN NaCl_NNP ,_, 2_CD ._. 5_CD mM_NN
          KCl_NNP ,_, 1_CD mM_NN MgCl_NNP 
          2_CD ,_, 5_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 6_CD )_) for_IN 1_CD ._. 5_CD -_: 3_CD
          hours_NNS ._. The_DT cells_NNS were_VBD then_RB rinsed_JJ and_CC stored_VBD in_IN frog_NN
          Ringer_NNP 's_POS solution_NN (_( 96_CD mM_NN NaCl_NNP ,_, 2_CD mM_NN KCl_NNP ,_, 1_CD ._. 8_CD mM_NN CaCl_NNP 
          2_CD ,_, 1_CD mM_NN MgCl_NNP 
          2_CD ,_, 5_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 6_CD )_) at_IN 14_CD °_NN C_NNP ._.
          Oocytes_NNP were_VBD injected_VBN with_IN 50_CD nL_NN mRNA_NN solution_NN within_IN two_CD
          days_NNS of_IN harvest_NN ._.
        
        
          Electrophysiology_NNP
          Electrophysiological_NNP recordings_NNS and_CC /_NN or_CC biochemistry_NN
          were_VBD performed_VBN 4_CD -_: 8_CD days_NNS after_IN injection_NN ._. After_IN brief_JJ
          exposure_NN to_TO a_DT hypertonic_JJ medium_NN ,_, the_DT vitelline_NN membrane_NN
          was_VBD stripped_VBN from_IN each_DT oocyte_NN with_IN forceps_NNS ._. Outside-out_NNP
          patch-clamp_JJ recordings_NNS were_VBD made_VBN using_VBG symmetrical_JJ
          NaCl_NNP /_NN HEPES_NNP /_NN EDTA_NNP solutions_NNS consisting_VBG of_IN 130_CD mM_NN NaCl_NNP ,_, 10_CD
          mM_NN HEPES_NNP ,_, 1_CD mM_NN EDTA_NNP and_CC 10_CD mM_NN EGTA_NNP (_( pH_NN 7_CD ._. 2_LS )_) ._. Capsaicin_NNP
          was_VBD prepared_VBN as_IN a_DT 4_CD mM_NN stock_NN in_IN dry_JJ ethanol_NN and_CC was_VBD added_VBN
          to_TO the_DT extracellular_NN solution_NN only_RB ._. The_DT solution_NN bathing_NN
          the_DT extracellular_NN surface_NN of_IN the_DT patch_NN was_VBD changed_VBN using_VBG
          a_DT RSC-_NNP 200_CD rapid_JJ solution_NN changer_NN (_( Molecular_NNP Kinetics_NNP ,_,
          Pullman_NNP ,_, WA_NNP )_) ._. Unless_IN otherwise_RB indicated_VBD ,_, all_DT chemicals_NNS
          were_VBD purchased_VBN from_IN Sigma_NNP Chemical_NNP Co_NNP ._. (_( St_NNP ._. Louis_NNP ,_,
          MO_NNP )_) ._.
          Pipettes_NNP were_VBD polished_VBN to_TO a_DT resistance_NN of_IN 0_CD ._. 3_CD -_: 1_CD MΩ_NNP and_CC
          immediately_RB before_IN use_NN were_VBD dipped_VBN in_IN a_DT seal_NN glue_NN
          composed_VBN of_IN one_CD part_NN light_JJ mineral_NN oil_NN ,_, one_CD part_NN heavy_JJ
          mineral_NN oil_NN ,_, and_CC 10_CD %_NN parafilm_NN beads_NNS to_TO promote_VB formation_NN
          of_IN high-resistance_JJ seals_NNS [_NN 36_CD ]_NN ._. Currents_NNP were_VBD low_JJ
          pass-filtered_JJ at_IN 2_CD kHz_NN and_CC sampled_VBN at_IN a_DT 10_CD kHz_NN with_IN an_DT
          Axopatch_NNP 200_CD B_NNP (_( Axon_NNP Instruments_NNP ,_, Union_NNP City_NNP ,_, CA_NNP )_) ._. Data_NNP
          were_VBD acquired_VBN and_CC analyzed_VBN with_IN the_DT PULSE_NNP data_NN
          acquisition_NN software_NN (_( Instrutech_NNP ,_, Elmont_NNP ,_, NY_NNP )_) and_CC were_VBD
          plotted_VBD and_CC fit_VB using_VBG Igor_NNP Pro_FW (_( Wavemetrics_NNP Inc_NNP ._. ,_, Lake_NNP
          Oswego_NNP ,_, OR_NNP )_) ._. All_DT currents_NNS shown_VBN are_VBP difference_NN currents_NNS
          in_IN which_WDT the_DT current_NN in_IN the_DT patch_NN in_IN the_DT absence_NN of_IN
          capsaicin_NN has_VBZ been_VBN subtracted_VBN ._. All_DT dose-response_JJ curves_NNS
          were_VBD measured_VBN at_IN +_NN 100_CD mV_NN at_IN room_NN temperature_NN ._. Smooth_NNP
          curves_NNS shown_VBN in_IN dose-response_JJ relations_NNS are_VBP fits_VBZ with_IN the_DT
          Hill_NNP equation_NN :_:
          
          where_WRB I_PRP is_VBZ the_DT current_NN at_IN a_DT given_VBN concentration_NN of_IN
          capsaicin_NN ,_, Imax_NNP is_VBZ the_DT maximal_NN current_JJ ,_, K_NNP 
          ½ is_VBZ the_DT concentration_NN of_IN half-maximal_JJ
          activation_NN and_CC n_NN is_VBZ the_DT Hill_NNP coefficient_NN ._. Current-voltage_NNP
          relations_NNS were_VBD plotted_VBD using_VBG the_DT data_NNS obtained_VBN from_IN
          voltage_NN jumps_NNS from_IN -_: 100_CD to_TO +_NN 100_CD mV_NN for_IN 100_CD ms_NNS from_IN a_DT
          holding_VBG potential_NN of_IN 0_CD mV_NN ._. Data_NNP was_VBD normalized_JJ by_IN
          dividing_VBG the_DT values_NNS of_IN the_DT current_NN at_IN different_JJ voltages_NNS
          by_IN the_DT value_NN of_IN the_DT current_NN at_IN -_: 100_CD mV_NN ._. When_WRB pooled_VBN data_NNS
          are_VBP discussed_VBN in_IN the_DT text_NN ,_, they_PRP represent_VBP the_DT mean_NN ±_NN
          standard_JJ error_NN of_IN the_DT mean_NN (_( SEM_NNP )_) A_DT Student_NNP 's_POS t-test_JJ
          (_( two-tailed_JJ )_) was_VBD performed_VBN on_IN some_DT data_NNS ,_, as_IN discussed_VBN in_IN
          the_DT text_NN ._. The_DT significance_NN level_NN was_VBD set_VBN at_IN p_NN >_NN
          0_CD ._. 05_CD ._.
        
        
          Mutagenesis_NNP
          A_DT potential_JJ glycosylation_NN site_NN was_VBD identified_VBN by_IN
          screening_VBG the_DT predicted_VBN vanilloid_NN receptor_NN 1_CD (_( VR_NNP 1_LS )_)
          channel_NN amino_JJ acid_NN sequence_NN [_NN 9_CD ]_NN ._. A_DT glycosylation_NN
          consensus_NN sequence_NN of_IN N-X-T_NNP /_NN S_NNP was_VBD found_VBN at_IN positions_NNS
          604_CD -_: 606_CD (_( NNS_NNP )_) ._. A_DT point_NN mutant_JJ was_VBD constructed_VBN as_IN outlined_VBN
          below_IN to_TO replace_VB the_DT asparagine_NN at_IN position_NN 604_CD with_IN a_DT
          serine_NN ._. The_DT mutant_JJ construct_VB was_VBD designated_VBN as_IN N_NNP 604_CD S_NNP ._.
          The_DT point_NN mutation_NN and_CC deletion_NN mutation_NN were_VBD
          constructed_VBN by_IN a_DT method_NN involving_VBG oligonucleotides_NNS
          synthesized_JJ to_TO contain_VB a_DT mutation_NN in_IN combination_NN with_IN
          wild-type_JJ oligonucleotides_NNS in_IN PCR_NNP amplifications_NNS of_IN
          fragments_NNS of_IN the_DT cDNA_NN ._. The_DT product_NN of_IN the_DT PCR_NNP reaction_NN
          was_VBD then_RB cut_VB with_IN two_CD different_JJ restriction_NN enzymes_NNS to_TO
          generate_VB a_DT cassette_NN containing_VBG the_DT mutation_NN ._. The_DT cassette_NN
          was_VBD then_RB ligated_JJ into_IN the_DT channel_NN cDNA_NN cut_NN with_IN the_DT same_JJ
          two_CD restriction_NN enzymes_NNS ._. After_IN transformation_NN of_IN bacteria_NNS
          with_IN the_DT ligation_NN product_NN ,_, single_JJ isolates_VBZ were_VBD selected_VBN ,_,
          and_CC the_DT entire_JJ region_NN of_IN the_DT amplified_VBN cassettes_NNS was_VBD
          sequenced_JJ to_TO check_VB for_IN the_DT mutation_NN and_CC insure_VB against_IN
          second-site_JJ mutations_NNS ._. mRNA_NN was_VBD synthesized_JJ in_IN vitro_NN ,_,
          using_VBG a_DT standard_JJ reverse-transcription_JJ kit_NN (_( mMessage_NN
          mMachine_NN ,_, Ambion_NNP ,_, Austin_NNP ,_, TX_NNP )_) ._. All_DT constructs_NNS ,_, including_VBG
          VR_NNP 1_CD ,_, were_VBD made_VBN in_IN a_DT background_NN of_IN a_DT VR_NNP 1_CD subunit_NN in_IN which_WDT
          the_DT FLAG_NNP epitope_NN (_( DYKDDDDK_NNP )_) had_VBD been_VBN spliced_JJ on_IN to_TO the_DT
          C-_NNP terminus_JJ ._. The_DT presence_NN of_IN this_DT epitope_NN was_VBD found_VBN to_TO
          have_VB no_DT detectable_JJ effects_NNS on_IN the_DT electrophysiological_JJ
          properties_NNS of_IN the_DT channels_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          SDS_NNP /_NN PAGE_NNP and_CC Western_JJ blot_NN
          Oocytes_NNP were_VBD prepared_VBN after_IN the_DT method_NN of_IN Rho_NNP 
          et_CC al_NN ._. [_NN 29_CD ]_NN ._. Typically_RB 30_CD
          oocytes_NNS were_VBD lysed_JJ by_IN trituration_NN in_IN 200_CD μL_NN of_IN a_DT solution_NN
          containing_VBG 100_CD mM_NN Tris-_NNP HCl_NNP ,_, 100_CD mM_NN NaCl_NNP ,_, 0_CD ._. 5_CD %_NN Triton_NNP
          X-_NNP 100_CD ,_, 0_CD ._. 05_CD mg_NN /_NN mL_NN pepstatin_NN ,_, 0_CD ._. 05_CD mg_NN /_NN mL_NN leupeptin_NN ,_, and_CC
          0_CD ._. 05_CD mg_NN /_NN mL_NN aprotinin_NN (_( pH_NN 8_CD ._. 0_CD )_) and_CC the_DT homogenate_NN was_VBD
          incubated_JJ for_IN 15_CD minutes_NNS on_IN ice_NN ._. The_DT homogenate_NN was_VBD then_RB
          centrifuged_JJ at_IN 18_CD ,_, 400_CD g_SYM for_IN ten_CD minutes_NNS at_IN 4_CD °_NN C_NNP in_IN a_DT Jouan_NNP
          CR_NNP 3_CD i_NNP centrifuge_NN ._. The_DT soluble_JJ portion_NN of_IN the_DT homogenate_NN
          was_VBD then_RB transferred_VBN to_TO a_DT new_JJ tube_NN for_IN an_DT additional_JJ
          centrifugation_NN ._. 10_CD μL_NN of_IN supernatant_NN was_VBD removed_VBN ,_, mixed_VBN
          with_IN 20_CD μL_NN of_IN Laemmli_NNP sample_NN buffer_NN containing_VBG
          β-mercaptoethanol_JJ (_( 19_CD :_: 1_LS )_) and_CC incubated_JJ at_IN room_NN
          temperature_NN for_IN five_CD minutes_NNS ._. The_DT samples_NNS were_VBD then_RB
          subjected_VBN to_TO SDS_NNP /_NN PAGE_NNP using_VBG NuPage_NNP 3_CD -_: 8_CD %_NN or_CC 7_CD %_NN
          Tris-_NNP Acetate_NNP precast_NN gels_NNS (_( Invitrogen_NNP Corp_NNP ._. ,_, Carlsbad_NNP ,_,
          CA_NNP )_) ._. Proteins_NNPS were_VBD then_RB transferred_VBN to_TO a_DT PVDF_NNP membrane_NN
          and_CC Western_JJ blot_NN analysis_NN was_VBD performed_VBN ._. For_IN all_DT blots_NNS
          except_IN that_DT shown_VBN in_IN Figure_NN 2_CD B_NNP ,_, M_NNP 2_CD anti-_NN FLAG_NNP primary_JJ
          antibody_NN was_VBD used_VBN ,_, and_CC for_IN the_DT blot_NN shown_VBN in_IN Figure_NN 2_CD Ba_NNP
          polyclonal_NN antibody_NN raised_VBD against_IN the_DT N-_NNP terminal_NN
          sequence_NN of_IN VR_NNP 1_CD (_( amino_JJ acids_NNS 4_CD -_: 21_CD :_: RASLDSEESESPPQENSC_NNP )_)
          was_VBD used_VBN (_( Neuromics_NNP Inc_NNP ._. ,_, Minneapolis_NNP ,_, MN_NNP )_) ._.
          Chemiluminescent_NNP detection_NN was_VBD then_RB carried_VBN out_IN using_VBG the_DT
          SuperSignal_NNP West_NNP Femto_NNP kit_NN (_( Pierce_NNP ,_, Rockford_NNP ,_, IL_NNP )_) ._.
          Chemiluminescent_NNP signals_NNS were_VBD captured_VBN with_IN the_DT Flourchem_NNP
          Imager_NNP (_( Alpha_NNP Innotech_NNP ,_, San_NNP Leandro_NNP ,_, CA_NNP )_) ,_, which_WDT has_VBZ a_DT
          linear_JJ range_NN of_IN 4_CD O_NNP ._. D_NNP ._. units_NNS ._. Densitometry_NNP of_IN bands_NNS on_IN
          Western_JJ blots_NNS was_VBD done_VBN with_IN the_DT Flourchem_NNP software_NN ._. For_IN
          comparison_NN of_IN the_DT ratio_NN of_IN monomer_NN to_TO dimer_NN ,_, we_PRP included_VBD
          both_DT monomer_NN bands_NNS in_IN the_DT monomer_NN category_NN ._. Because_IN of_IN
          the_DT large_JJ linear_JJ range_NN of_IN detection_NN of_IN our_PRP$ instrument_NN ,_, we_PRP
          could_MD compare_VB this_DT ratio_NN with_IN accuracy_NN even_RB if_IN the_DT amount_NN
          of_IN total_JJ protein_NN varied_VBD between_IN gels_NNS ._.
          For_IN SDS_NNP /_NN PAGE_NNP experiments_NNS on_IN disulfide_NN bonds_NNS ,_, the_DT
          oocytes_NNS were_VBD treated_VBN as_IN above_IN ,_, except_IN that_IN the_DT lysis_NNS
          buffer_NN contained_VBD either_CC 100_CD mM_NN DTT_NNP or_CC 20_CD mM_NN Tris_NNP
          (_( 2_CD -_: Carboxyethyl_NNP )_) Phosphine_NNP Hydrochloride_NNP (_( TCEP_NNP )_) (_( Pierce_NNP ,_,
          Rockford_NNP ,_, IL_NNP )_) ._. To_TO examine_VB the_DT effect_NN of_IN calcium_NN and_CC
          capsaicin_NN on_IN VR_NNP 1_CD dimer_NN formation_NN ,_, four_CD different_JJ
          conditions_NNS were_VBD tested_VBN ._. For_IN calcium-free_JJ condition_NN ,_, whole_JJ
          oocytes_NNS were_VBD rinsed_JJ three_CD times_NNS with_IN calcium-free_JJ frog_NN
          Ringer_NNP 's_POS solution_NN (_( 96_CD mM_NN NaCl_NNP ,_, 2_CD mM_NN KCl_NNP ,_, 2_CD mM_NN EGTA_NNP ,_, 1_CD mM_NN
          MgCl_NNP 
          2_CD ,_, 5_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 6_CD )_) prior_RB to_TO
          incubation_NN with_IN or_CC without_IN 10_CD -_: 20_CD μM_NN capsaicin_NN at_IN room_NN
          temperature_NN for_IN 30_CD minutes_NNS ._. For_IN calcium-_NN present_JJ
          condition_NN ,_, whole_JJ oocytes_NNS were_VBD bathed_VBN in_IN frog_NN Ringer_NNP 's_POS
          solution_NN with_IN or_CC without_IN 10_CD -_: 20_CD μM_NN capsaicin_NN for_IN the_DT same_JJ
          duration_NN ._. The_DT oocytes_NNS were_VBD triturated_JJ according_VBG to_TO the_DT
          method_NN described_VBD above_IN ,_, except_IN for_IN the_DT capsaicin-present_JJ
          condition_NN ,_, where_WRB 10_CD -_: 20_CD μM_NN capsaicin_NN was_VBD included_VBN in_IN the_DT
          lysis_NNS buffer_NN ._. For_IN experiments_NNS on_IN transglutaminase_NN
          inhibitors_NNS ,_, the_DT oocytes_NNS were_VBD bathed_VBN for_IN one_CD hour_NN in_IN frog_NN
          Ringer_NNP 's_POS solution_NN containing_VBG either_CC 20_CD mM_NN cysteamine_NN or_CC
          250_CD μM_NN MDC_NNP ._. These_DT are_VBP expected_VBN to_TO be_VB saturating_VBG
          concentrations_NNS of_IN the_DT transglutaminase_NN inhibitors_NNS ._.
          Oocytes_NNP were_VBD triturated_JJ according_VBG to_TO the_DT method_NN above_IN ,_,
          except_IN that_DT either_DT 20_CD mM_NN cysteamine_NN or_CC 250_CD μM_NN MDC_NNP were_VBD
          included_VBN in_IN the_DT lysis_NNS buffer_NN ._.
        
      
    
  
